GLY-OH Vasopressin - Request Quote
GLY-OH Vasopressin
| SZ CAT No: | SZ-V028007 |
| CAS No | NA |
| Mol.F. | C46H64N14O13S2 |
| Mol.Wt. | 1085.2 |
| Inv. Status | In Stock |
| Shipping Condition | Cold Shipment 2-8°C |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
GLY-OH Vasopressin is chemically ((4R,7S,10S,13S,16S)-20-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-prolyl-L-arginylglycine. GLY-OH Vasopressin is supplied with detailed characterization data compliant with regulatory guideline. GLY-OH Vasopressin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vasopressin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality GLY-OH Vasopressin
Purchase GLY-OH Vasopressin
GLY-OH Vasopressin suppliers
GLY-OH Vasopressin manufacturers
GLY-OH Vasopressin price
Order GLY-OH Vasopressin
Enquire GLY-OH Vasopressin
GLY-OH Vasopressin cost
GLY-OH Vasopressin Supplier
GLY-OH Vasopressin Distributor
GLY-OH Vasopressin for Method Validation
Vasopressin Reference Standard
GLY-OH Vasopressin for ANDA Filing
GLY-OH Vasopressin for Forced Degradation Studies
GLY-OH Vasopressin Identification Standards
GLY-OH Vasopressin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


